SeaStar Medical believes that initial results from the SAVE Surveillance Registry will support broader adoption of the QUELIMMUNE therapy, inform payer discussions, and complement the company’s ...

SeaStar Medical Holding Corp., the commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, has made a ...

DENVER, July 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today positive preliminary results from the SAVE ...

SeaStar Medical is currently conducting the NEUTRALIZE-AKI pivotal trial that is evaluating the safety and efficacy of the SCD therapy in 200 adults with AKI in the ICU receiving CRRT.

DENVER - SeaStar Medical Holding Corporation (Nasdaq:ICU), a micro-cap biotech company with a market capitalization of $15.38 million, announced Tuesday preliminary results from its SAVE ...

SeaStar Medical reports positive preliminary results for QUELIMMUNE therapy in critically ill children with Acute Kidney Injury and sepsis.

SeaStar Medical believes that initial results from the SAVE Surveillance Registry will support broader adoption of the QUELIMMUNE therapy, inform payer discussions, and complement the company’s ...

The intended acquisition of Dornier Hinneburg in Germany would be an important move for Bureau Veritas to expand its services to the growing nuclear sector. The company provides technical advisory ...

Get the latest SeaStar Medical Holding Corporation (ICU) stock news and headlines to help you in your trading and investing decisions.

The latest CD Private Equity Fund II [CD2] news, articles, data and analysis from The Australian Financial Review ...